Androgen receptor (AR) and hypoxia inducible factor 1a (HIF1a) are transcription factors that promote prostate cancer progression and radioresistance. This study investigated the relationship between the AR and HIF1a signaling pathways
Most human solid tumours contain areas which are less oxygenated than normal tissues. Hypoxia increa...
BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Prostate cancer is the most commonly diagnosed\r\ncancer in men and the second leading cause of canc...
Background: Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for pros...
BACKGROUND: Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for pros...
Tumors are complex tissues in which transformed cells communicate with the surrounding microenviron...
Background: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Tumors are complex tissues in which transformed cells communicate with the surrounding microenvironm...
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that regulates genes involved in adapta...
BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Prostate cancer progression is controlled by the androgen receptor and new blood vessel formation, o...
BACKGROUND. Hypoxia induces increased tumor growth by promoting angiogenic and glycolytic pathways. ...
Androgen Receptor (AR)-signaling plays a critical role in the development and progression of prostat...
© 2016 Dr. Weranja Kalana Bodhisiri RanasingheProstate cancer (PC) is one of the most prevalent canc...
BACKGROUND: FOXP1 is a member of the winged helix or forkhead transcription factors. Recent studies ...
Most human solid tumours contain areas which are less oxygenated than normal tissues. Hypoxia increa...
BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Prostate cancer is the most commonly diagnosed\r\ncancer in men and the second leading cause of canc...
Background: Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for pros...
BACKGROUND: Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for pros...
Tumors are complex tissues in which transformed cells communicate with the surrounding microenviron...
Background: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Tumors are complex tissues in which transformed cells communicate with the surrounding microenvironm...
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that regulates genes involved in adapta...
BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Prostate cancer progression is controlled by the androgen receptor and new blood vessel formation, o...
BACKGROUND. Hypoxia induces increased tumor growth by promoting angiogenic and glycolytic pathways. ...
Androgen Receptor (AR)-signaling plays a critical role in the development and progression of prostat...
© 2016 Dr. Weranja Kalana Bodhisiri RanasingheProstate cancer (PC) is one of the most prevalent canc...
BACKGROUND: FOXP1 is a member of the winged helix or forkhead transcription factors. Recent studies ...
Most human solid tumours contain areas which are less oxygenated than normal tissues. Hypoxia increa...
BACKGROUND: Castrate-resistant prostate cancer (CRPC) is a lethal condition in patients receiving an...
Prostate cancer is the most commonly diagnosed\r\ncancer in men and the second leading cause of canc...